Scientists from Yale University have developed an improved pharmacological treatment using nanotechnology that eliminates inflammation and prevents infection during kidney transplants.
This new procedure may help with the long-term outcomes of patients that have received kidney transplants. The process involves pumping warm, oxygenated red blood cells through an organ that has been removed from a deceased donor.
The purpose of this is to repair any kidney damage and give physicians time to assess the quality of the organ. This process can also help increase the number of organs that are suitable for transplant.
In collaboration with researchers from the University of Cambridge, Yale researchers are working to expand patients’ rehabilitation abilities through a nanoparticle-based system.
This procedure allows for a variety of treatments to be provided directly to critical targets in a human kidney while it is still outside the body.
“We think it can not only provide new therapeutic strategies for organ transplant, but it also has the potential to provide new insights for systemic drug delivery,” state the lead researchers from Yale University.
Learn about the complete results of the research in Science Translational Medicine.